3 studies found for:    19064971 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma
Conditions: Lymphoma;   Precancerous/Nonmalignant Condition
Interventions: Biological: PEG-interferon alfa-2b;   Biological: Interferon alfa-2b;   Drug: Valproic Acid;   Drug: Zidovudine;   Genetic: Molecular Evaluation/Analysis of Malignant Clones of ATLL;   Genetic: NF-kB Inhibition
2 Active, not recruiting EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
Condition: Leukemia-Lymphoma, Adult T-Cell
Interventions: Drug: Bortezomib;   Drug: Etoposide;   Drug: Vincristine;   Drug: Doxorubicin;   Drug: Prednisone;   Drug: Cyclophosphamide;   Drug: Raltegravir
3 Recruiting Ruxolitinib for Adult T-Cell Leukemia
Conditions: T Cell Leukemia, Adult;   Leukemia, Adult T-Cell;   T Cell Leukemia, HTLV I Associated
Intervention: Drug: Ruxolitinib

Indicates status has not been verified in more than two years